v3.25.1
SEGMENT INFORMATION (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting [Abstract]    
Clinical trials and other services from R&D-related service providers $ 1,893 $ 2,480
Payroll and related expenses, other than share-based compensation 2,385 1,199
Share-based compensation expenses 5,862 130
Depreciation 25 45
Other segment expenses [1] 2,406 827
OPERATING LOSS 12,571 4,681
Interest income 28 153
Interest expense (27) 0
Other financing expense, net 3,939 548
Income taxes 10 32
Net loss (16,519) (5,108)
Assets 2,863 5,256
Expenditures for segment assets $ (22) $ (12)
[1] Other segment expenses include mainly general and administrative-related expenses, such as payments to advisors and consultants, office lease expenses and maintenance, HR and legal expenses.